SCHEMBL22837937

SCHEMBL22837937

CC1(n2cnc3c(N)ncnc32)O[C@H](CNS(=O)(=O)NC2(c3ccccc3F)COC2)[C@@H](O)[C@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22837886 0.85 — —
SCHEMBL20711325 0.82 — —
SCHEMBL22837884 0.78 GMPS (0.34) —
SCHEMBL22837885 0.77 TRPM2 (0.36) —
SCHEMBL20711232 0.75 — —
SCHEMBL20711234 0.74 TRPM2 (0.54) —
SCHEMBL20711210 0.71 TRPM2 (0.60) —
SCHEMBL20711235 0.71 — —
SCHEMBL16258664 0.71 PI4KA (0.55) —
SCHEMBL18680910 0.71 PI4KA (0.55) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10874686-B2 Anthranilyl-adenosinemonosulfamate analogs and uses thereof MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-12-29 — — US disclosed
Send feedback